MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Development and validation of diagnostic criteria for advanced Parkinson disease: the CDEPA questionnaire

    M.-R. Luquin, J. Kulisevsky, P. Martinez-Martin, P. Mir, E. Tolosa, P. Garcia-Delgado (Pamplona, Spain)

    Objective: Using the Delphi methodology we previously obtained a consensus on the definition and clinical characteristics of advanced Parkinson’s disease (APD). We aimed to develop…
  • 2017 International Congress

    Sports or no sports – is that the question in PD?

    M. Strothjohann, P. Kostopoulos, F. Weber (Bad Camberg, Germany)

    Objective: A multitude of risk factors or protective factors in developing Parkinson’s Disease (PD) are under discussion, as caffeine consumption or smoking ..  Background: Frequent physical activity…
  • 2017 International Congress

    Medication optimization in Parkinson’s disease patients with ON-state freezing using objective gait assessments

    T. Virmani (Little Rock, AR, USA)

    Objective: To determine whether objective gait assessments could guide therapeutic decision making in Parkinson’s disease (PD) patients reporting freezing of gait (FOG) in the levodopa-ON…
  • 2017 International Congress

    Objective biomarkers of posture balance for early and advanced Parkinson’s disease

    I. Miliukhina, E. Gracheva, A. Kudrevatykh, T. Sergeev, M. Didur (Saint-Petersburg, Russian Federation)

    Objective: The aim of this study was to investigate the postural performance of patients with early and advanced Parkinson's disease (PD) using computerized posturography. Background:…
  • 2017 International Congress

    Segregation of subjective and objective clinical measures in Parkinson’s disease

    K. Markopoulou, R. Frigerio, A. Premkumar, B. Schoneburg, M. Dudek, S. Walters, C. Wang, D. Maraganore (Evanston, IL, USA)

    Objective: Use standardized measures to characterize disease severity, progression, and outcomes in Parkinson’s disease (PD). Background: Subjective and objective standardized measures are usually performed in…
  • 2017 International Congress

    Assessing Bone Health in Parkinson’s – When and how?

    A. Dzharif, E. Thomas, B. Mohamed, T. Williams, S. Mahon (Cardiff, United Kingdom)

    Objective: To assess the impact of, and practicality of, assessing bone health routinely in people newly diagnosed with Parkinson’s disease in a South Wales University…
  • 2017 International Congress

    Determinants of balance confidence and concern about falling in people with Parkinson’s disease

    L. Almeida, G. Valenca, E. Pinto, J. Oliveira-Filho (Salvador, Brazil)

    Objective: To identify factors that contribute to balance confidence and concern about falling in people with Parkinson’s disease (PD). Background: Reduced balance confidence and greater…
  • 2017 International Congress

    Leg Stereotypy Disorder: Clinical Characteristics and Prevalence

    J. Jankovic, M. Lotia, M. York, A. Strutt (Houston, TX, USA)

    Objective: To describe phenomenology and prevalence of leg stereotypy disorder (LSD) Background: LSD is characterized chiefly by repetitive, rhythmical, stereotyped leg movement when sitting (Jankovic…
  • 2017 International Congress

    Factors associated with occurrence of motor complications among Parkinson’s disease patients with levodopa treatment in Estonia

    L. Kadastik-Eerme, N. Taba, T. Asser, P. Taba (Tartu, Estonia)

    Objective: To identify the factors associated with the occurrence of motor complications among patients with Parkinson’s disease (PD) who receive levodopa treatment. Background:  Levodopa is the…
  • 2017 International Congress

    Tongue strength in Parkinson’s disease.

    H. Kalf, J. van Asperen, F. Tuenter, L. van Vucht, J. Vanderwegen, G. van Nuffelen (Nijmegen, Netherlands)

    Objective: To investigate tongue strength in patients with Parkinson’s disease and the relation with speech and swallowing. Background: Motor disorders in Parkinson’s disease (PD) are…
  • « Previous Page
  • 1
  • …
  • 1481
  • 1482
  • 1483
  • 1484
  • 1485
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley